Share This Page
Drug Price Trends for NDC 71930-0079
✉ Email this page to a colleague
Average Pharmacy Cost for 71930-0079
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| HYDROCORTISONE 10 MG TABLET | 71930-0079-12 | 0.22315 | EACH | 2025-11-19 |
| HYDROCORTISONE 10 MG TABLET | 71930-0079-12 | 0.22452 | EACH | 2025-10-22 |
| HYDROCORTISONE 10 MG TABLET | 71930-0079-12 | 0.22801 | EACH | 2025-09-17 |
| HYDROCORTISONE 10 MG TABLET | 71930-0079-12 | 0.22892 | EACH | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 71930-0079
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 71930-0079
Introduction
This report provides a comprehensive market analysis and price projection for the drug identified by National Drug Code (NDC) 71930-0079. Recognized within the pharmaceutical industry, this NDC corresponds to a specific formulation and manufacturer. Accurate valuation and strategic positioning require understanding the drug’s therapeutic landscape, competitive environment, regulatory factors, and economic considerations. This analysis aligns with industry trends, payer dynamics, and pricing models to aid stakeholders in making informed decisions.
Product Overview and Therapeutic Landscape
NDC 71930-0079 represents a proprietary formulation indicated for [specify indication if available], catering to a substantial segment of the [relevant therapeutic class, e.g., oncology, diabetes, autoimmune disorders]. Depending on its pharmacological profile—such as monoclonal antibody, small molecule, or biosimilar—the drug’s positioning is influenced by its efficacy, safety profile, and mode of administration.
The current market includes multiple competitors, such as [list dominant players if known, e.g., Eli Lilly, Novartis, or Amgen], emphasizing the importance of differentiation through efficacy, cost, and patent protections. The therapeutic landscape is evolving rapidly, with increasing emphasis on biosimilars and personalized medicine, which impact product demand and pricing.
Regulatory Status and Market Penetration
NDC 71930-0079's regulatory approval status significantly influences its market potential and pricing strategy. Whether approved by the FDA or other regional authorities, the scope of indication expansion, designated orphan status, or expedited review pathways (like Breakthrough Therapy) determines the speed of market entry and commercialization.
Market penetration is currently shaped by:
- Reimbursement pathways: coverage decisions by Medicare, Medicaid, private insurers, and pharmacy benefit managers influence patient access.
- Pricing landscape: existing list prices, discounts, and negotiated rebates shape net revenue.
- Supply chain considerations: manufacturing capacity, distribution channels, and inventory management impact availability.
Competitive Environment and Market Dynamics
The competitive landscape for NDC 71930-0079 hinges upon available therapeutic alternatives:
- Brand-name competitors: Existing patented drugs with established efficacy.
- Biosimilars or generics: Their entry can exert downward pressure on pricing.
- Innovative therapies: Advancements such as gene therapy or digital health integration altering treatment paradigms.
Market growth is projected to be driven by increasing prevalence of the target condition, emergence of combination therapies, and expanding indications. Conversely, patent cliffs, biosimilar entry, and payer resistance threaten revenue streams.
Market Size and Demand Trends
Based on recent epidemiological data:
- Prevalence: The target condition affects approximately [insert prevalence figures], with a growing trend due to factors like aging populations and lifestyle changes.
- Treatment rates: Currently, an estimated [percentage] of eligible patients receive the therapy, with potential for expansion through increased awareness and clinical adoption.
- Growth rate: The compound annual growth rate (CAGR) for the therapeutic market segment stands at approximately [X]% over the next five years, influenced by technological innovations and policy changes.
Pricing Analysis and Projections
Current Price Benchmarks:
The current average wholesale price (AWP) for similar therapies in this category ranges from $[lowerbound]-[upperbound] per unit. Payer-negotiated net prices often fall below these benchmarks due to rebates.
Factors Influencing Price Trajectory:
- Patent protections and exclusivity: Extended patents can sustain higher prices, with upcoming expirations potentially causing price erosion.
- Market competition: Entry of biosimilars and generics is anticipated to reduce prices by an estimated [X]% within 3–5 years.
- Regulatory and policy shifts: Price controls or value-based reimbursement approaches may restrict maximum allowable prices.
- Value-based pricing models: Emphasizing clinical outcomes may enable premium pricing if the drug demonstrates superior efficacy.
Projected Price Evolution:
Assuming stable patent protection, initial launch prices are expected to be around $[initial price] per dose/therapy course. Over a 5-year horizon, prices may decline by [X]% due to increased competition, reaching approximately $[projected price].
Reimbursement and Discounting Trends:
Net prices could be further influenced by negotiated rebates and discounts, potentially reducing effective revenue by [X]%.
Revenue and Market Share Projections
Based on projected demand and pricing:
| Year | Estimated Units Sold | Average Price per Unit | Expected Revenue |
|---|---|---|---|
| 2023 | [units] | $[price] | $[revenue] |
| 2024 | [units] | $[price] | $[revenue] |
| 2025 | [units] | $[price] | $[revenue] |
Market share assumptions account for competitive dynamics, with an initial market penetration rate of [X]%, expanding as awareness and clinical adoption grow.
Risk Factors and Strategic Considerations
Key risks include:
- Regulatory delays or denials, which could protract time to market.
- Pricing pressures from biosimilar entry or payer negotiations.
- Market acceptance influenced by clinical data and physician preferences.
- Manufacturing and supply chain disruptions leading to availability issues.
Strategic considerations involve:
- Investing in comparative effectiveness research to demonstrate value.
- Negotiating favorable reimbursement terms early.
- Pursuing strategic partnerships for distribution and market access.
Regulatory and Policy Outlook
Potential regulatory reforms targeting drug pricing and reimbursement policies globally could impact profitability. In the U.S., increased scrutiny on drug costs could result in more aggressive negotiations or legislation aimed at price capping. Elsewhere, regional health authorities are exploring value-based assessments and pay-for-performance models, which could influence future pricing strategies.
Conclusion
NDC 71930-0079 is positioned within a dynamic and competitive pharmaceutical landscape. Its pricing trajectory depends critically on patent exclusivity, clinical differentiation, and market acceptance. While initial prices are likely to be maintained at premium levels, imminent biosimilar competition and regulatory pressures suggest a downward trend over the next five years. Strategic planning centered on value demonstration and early payer engagement will be crucial for optimizing market share and revenue growth.
Key Takeaways
- The drug's market price is expected to decline by approximately [X]% within five years, primarily due to biosimilar competition.
- Robust clinical differentiation and evidence generation are vital to sustain premium pricing.
- Strategic negotiations with payers and early access programs will influence net revenue outcomes.
- Patent protections and regulatory landscape are key determinants of pricing and market exclusivity.
- Monitoring policy changes nationally and internationally will be essential to adapt pricing strategies.
FAQs
1. What factors influence the price of NDC 71930-0079?
Pricing is influenced by patent status, therapeutic efficacy, competition (biosimilars/generics), payer negotiations, and regulatory policies.
2. How does biosimilar entry affect the market for this drug?
Biosimilar entry typically exerts downward pressure on prices, reducing profit margins and potential revenue.
3. What is the expected timeline for price erosion?
Significant price reductions are expected within 3–5 years post-launch due to biosimilar competition and regulatory pressures.
4. How can manufacturers maintain market share amid rising competition?
Investing in clinical superiority, demonstrating added value, and establishing favorable payer arrangements are key strategies.
5. What regulatory trends could impact future pricing?
Increased focus on value-based pricing, drug price caps, and transparency initiatives may restrict pricing flexibility moving forward.
References
- [Insert relevant industry reports, regulatory agency data, and market research sources.]
- [Cited epidemiological and market data sources.]
- [Pricing benchmarks from industry publications.]
More… ↓
